This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Population with cardiovascular risk receiving drug therapy and counseling: a Brazilian perspective on the global target, 2014-2015 / Población de riesgo cardiovascular que recibe medicamento y asesoramiento: la perspectiva de Brasil sobre el objetivo mundial, 2014-2015 / População com risco cardiovascular elevado em uso de medicamento e aconselhamento: a situação do Brasil em relação à meta mundial, 2014-2015
Preprint
in Portuguese
| SciELO Preprints
| ID: pps-1929
Responsible library:
BR1.1
ABSTRACT
Objective:
To estimate the prevalence of high cardiovascular risk (CVR) and the proportion of people with high CVR who receive treatment and counseling, to investigate the sociodemographic factors associated with this outcome, in Brazil.Methods:
Cross-sectional study, using subsample data from the National Health Survey, collected by biochemical tests, in 2014-2015. Poisson regression was used.Results:
The proportion of high CVR in men was 11.2% (95%CI 9.6;12.9), and in women 10.4% (95%CI 9.2;11.8%). In the group with high CVR, 68.8% (95%CI 63.7;73.4%) received counseling, 59.3% (95%CI 54.2;64.3%) medication, and 55.6% (95%CI 50.4;60.7%) both. In the multivariate analysis, receiving treatment and counseling was associated with age 50 years and over, and poor/very poor health self-assessment (PR=1.26 95%CI 1.06;1.51).Conclusion:
The proportion of people with elevated CVR who received treatment and counseling was over 50%.RESUMO
Objetivo:
Estimar a prevalência de risco cardiovascular (RCV) elevado, a proporção de pessoas com RCV elevado que recebem tratamento e aconselhamento, e investigar os fatores sociodemográficos associados ao desfecho, no Brasil.Métodos:
Estudo transversal, com dados de subamostra da Pesquisa Nacional de Saúde, coletados por exames bioquímicos, em 2014-2015. Empregou-se regressão de Poisson.Resultados:
A proporção de RCV elevado em homens foi de 11,2% (IC95% 9,6;12,9) e em mulheres de 10,4% (IC95% 9,2;11,8%). No grupo com RCV elevado, 68,8% (IC95% 63,7;73,4%) receberam aconselhamento, 59,3% (IC95% 54,2;64,3%) medicamento e 55,6% (IC95% 50,4;60,7%) ambos. Na análise multivariável, receber tratamento e aconselhamento mostrou associação com a idade de 50 anos e mais, e com autoavaliação de saúde ruim/muito ruim (RP=1,26 IC95% 1,06;1,51).Conclusão:
A proporção de pessoas com RCV elevada que receberam tratamento e aconselhamento foi superior a 50%.
Full text:
Available
Collection:
Preprints
Database:
SciELO Preprints
Type of study:
Etiology study
/
Observational study
/
Prevalence study
/
Risk factors
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Year:
2021
Document type:
Preprint
